Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Budapest - Delayed Quote HUF

NUTEX Investments Public Limited Company (NUTEX.BD)

19.20
-0.20
(-1.03%)
As of 9:26:01 AM GMT+2. Market Open.
Loading Chart for NUTEX.BD
  • Previous Close 19.40
  • Open 18.70
  • Bid 18.55 x --
  • Ask 19.00 x --
  • Day's Range 18.40 - 19.20
  • 52 Week Range 13.00 - 27.80
  • Volume 15,050
  • Avg. Volume 293,804
  • Market Cap (intraday) 3.041B
  • Beta (5Y Monthly) 1.42
  • PE Ratio (TTM) 6.17
  • EPS (TTM) 3.11
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 6, 2011
  • 1y Target Est --

NUTEX Investments Public Limited Company provides health preserving, health improving, dietary supplement, and cosmetic products in Hungary and internationally. The company was formerly known as HUMET Trade, Research and Development Public Limited Company and changed its name to NUTEX Investments Public Limited Company in February 2011. The company was incorporated in 1996 and is based in Budapest, Hungary.

www.nutex.hu

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NUTEX.BD

View More

Performance Overview: NUTEX.BD

Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

NUTEX.BD
11.93%
MSCI WORLD (^990100-USD-STRD)
4.85%

1-Year Return

NUTEX.BD
38.13%
MSCI WORLD (^990100-USD-STRD)
6.50%

3-Year Return

NUTEX.BD
62.71%
MSCI WORLD (^990100-USD-STRD)
22.76%

5-Year Return

NUTEX.BD
33.79%
MSCI WORLD (^990100-USD-STRD)
79.22%

Compare To: NUTEX.BD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NUTEX.BD

View More

Valuation Measures

Annual
As of 4/23/2025
  • Market Cap

    3.07B

  • Enterprise Value

    -1.99B

  • Trailing P/E

    6.24

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.39k

  • Price/Book (mrq)

    0.54

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    103,075.55%

  • Return on Assets (ttm)

    -0.22%

  • Return on Equity (ttm)

    8.42%

  • Revenue (ttm)

    450k

  • Net Income Avi to Common (ttm)

    463.84M

  • Diluted EPS (ttm)

    3.11

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.07B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -633.08M

Research Analysis: NUTEX.BD

View More

Company Insights: NUTEX.BD

Research Reports: NUTEX.BD

View More

People Also Watch